Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

The talks around drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices ...

The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The price negotiations for the additional 15 drugs selected will be handled by the incoming Trump administration and, if ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

Wegovy, Ozempic added to list of drugs where the federal government will try winning discounts from manufacturers.

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic ...

Drug prices are up for negotiation on 15 Medicare Part D prescription drugs, including popular weight loss drugs such as Ozempic.

People will be able to carry a list of their current ­medications in the first HSE app that is due to be available to download in March. The app, which will have ­limited functions initially, will ...